We are live on ! Find out more
GRCE

Grace Therapeutics
GRCE

12 hedge funds and large institutions have $1.48M invested in Grace Therapeutics in 2015 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 1

20% less funds holding

Funds holding: 15 → 12 (-3)

48% less capital invested

Capital invested by funds: $2.87M → $1.48M (-$1.39M)

50% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 6

Holders
12
Holders Change
-3
Holders Change %
-20%
% of All Funds
0.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
4
Reduced
1
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$407K
2
Renaissance Technologies
Renaissance Technologies
New York
+$35.5K
3
Deutsche Bank
Deutsche Bank
Germany
+$472
4
TRCT
Tower Research Capital (TRC)
New York
+$472
5
UBS Group
UBS Group
Switzerland
+$354

Top Sellers

Rank Fund Capital Flow
1
Fiera Capital (Canada)
Fiera Capital (Canada)
Quebec, Canada
-$1.55M
2
IIM
Intact Investment Management
Quebec, Canada
-$111K
3
1832 Asset Management
1832 Asset Management
Ontario, Canada
-$69K
4
Citadel Advisors
Citadel Advisors
Florida
-$10K
5
Geode Capital Management
Geode Capital Management
Massachusetts
-$4K
Name Holding Trade Value Shares
Change 		Change in
Stake
PA
1
Perceptive Advisors
New York
$594K – – –
Bank of Montreal
2
Bank of Montreal
Ontario, Canada
$537K +$407K +3,454 +371%
IIM
3
Intact Investment Management
Quebec, Canada
$287K -$111K -944 -34%
Renaissance Technologies
4
Renaissance Technologies
New York
$53K +$35.5K +301 +225%
UBS Group
5
UBS Group
Switzerland
$4K +$354 +3 +9%
EWM
6
Edge Wealth Management
New York
$1K – – –
LTFS
7
Ladenburg Thalmann Financial Services
Florida
$1K – – –
Royal Bank of Canada
8
Royal Bank of Canada
Ontario, Canada
$1K +$236 +2 +20%
TRCT
9
Tower Research Capital (TRC)
New York
$1K +$472 +4 New
CS
10
Credential Securities
$27 – – –
Fiera Capital (Canada)
11
Fiera Capital (Canada)
Quebec, Canada
– -$1.55M -1,295 Closed
1832 Asset Management
12
1832 Asset Management
Ontario, Canada
– -$69K -568 Closed
Citadel Advisors
13
Citadel Advisors
Florida
– -$10K -75 Closed
Geode Capital Management
14
Geode Capital Management
Massachusetts
– -$4K -38 Closed
VKH
15
Virtu KCG Holdings
New York
– -$3K -23 Closed
AGM
16
Alpine Global Management
New York
– -$3K -21 Closed
Citigroup
17
Citigroup
New York
– +$118 +1 New
Deutsche Bank
18
Deutsche Bank
Germany
– +$472 +4 New

GRCE Hedge Fund Activity: Q4 2015 in Review

12 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in Grace Therapeutics (GRCE) for Q4 2015, worth a combined $1.48M — down 48% from $2.87M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of GRCE and 3 opened new positions — a net loss of 3 holders — while 1 trimmed existing stakes and 4 added.

The largest buyer was Bank of Montreal, adding an estimated $407K. The largest seller was Fiera Capital (Canada), exiting entirely with an estimated $1.55M sold.

  • 12 institutional investors held Grace Therapeutics (GRCE) as of Q4 2015, down from 15 in Q3 2015.
  • Funds reported $1.48M of Grace Therapeutics stock for Q4 2015, down 48% quarter-over-quarter.
  • 3 funds opened new Grace Therapeutics positions in Q4 2015 and 6 closed out, a net change of -3 holders.
  • The largest Grace Therapeutics buyer in Q4 2015 was Bank of Montreal, an estimated $407K added.
  • The largest Grace Therapeutics seller in Q4 2015 was Fiera Capital (Canada), an estimated $1.55M sold.

Based on aggregated 13F filings for Q4 2015.